0 XP   0   0   0

ASIT Biotech S.A
Buy, Hold or Sell?

Should you buy, hold or sell ASIT Biotech S.A?

I guess you are interested in ASIT Biotech S.A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse ASIT Biotech S.A

Let's start. I'm going to help you getting a better view of ASIT Biotech S.A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is ASIT Biotech S.A even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how ASIT Biotech S.A is doing in the market. If the company is worth buying. The latest step is to find out how other investors value ASIT Biotech S.A. The closing price on 2022-02-04 was €0.229 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
ASIT Biotech S.A Daily Candlestick Chart
ASIT Biotech S.A Daily Candlestick Chart
Summary









1. Valuation of ASIT Biotech S.A




Current price per share

€0.23

2. Growth of ASIT Biotech S.A




Is ASIT Biotech S.A growing?

Current yearPrevious yearGrowGrow %
How rich?-$6.1m-$4.5m-$1.5m-25.9%

How much money is ASIT Biotech S.A making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$17m$15.5m1,049.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of ASIT Biotech S.A




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

1.1. Profitability of ASIT Biotech S.A.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ASIT Biotech S.A earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare ASIT Biotech S.A to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ASIT Biotech S.A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-39,322.9%+39,322.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
YOY--344.8%+344.8%
5Y--450.1%+450.1%
10Y-39,322.9%-541.0%-38,781.9%
1.1.2. Return on Assets

Shows how efficient ASIT Biotech S.A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ASIT Biotech S.A to the Biotechnology industry mean.
  • -26.5% Return on Assets means that ASIT Biotech S.A generated €-0.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ASIT Biotech S.A:

  • The MRQ is -26.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -26.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.5%TTM-26.5%0.0%
TTM-26.5%YOY-230.0%+203.5%
TTM-26.5%5Y-147.9%+121.4%
5Y-147.9%10Y-137.5%-10.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.5%-9.9%-16.6%
TTM-26.5%-8.9%-17.6%
YOY-230.0%-9.3%-220.7%
5Y-147.9%-11.7%-136.2%
10Y-137.5%-12.7%-124.8%
1.1.3. Return on Equity

Shows how efficient ASIT Biotech S.A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ASIT Biotech S.A to the Biotechnology industry mean.
  • 0.0% Return on Equity means ASIT Biotech S.A generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ASIT Biotech S.A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-263.0%+263.0%
5Y-263.0%10Y-862.0%+599.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.0%+12.0%
TTM--11.5%+11.5%
YOY--10.8%+10.8%
5Y-263.0%-14.2%-248.8%
10Y-862.0%-15.2%-846.8%

1.2. Operating Efficiency of ASIT Biotech S.A.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ASIT Biotech S.A is operating .

  • Measures how much profit ASIT Biotech S.A makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ASIT Biotech S.A to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ASIT Biotech S.A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-38,773.6%+38,773.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y--454.0%+454.0%
10Y-38,773.6%-537.1%-38,236.5%
1.2.2. Operating Ratio

Measures how efficient ASIT Biotech S.A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of ASIT Biotech S.A:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y388.151-388.151
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y-5.132-5.132
10Y388.1516.371+381.780

1.3. Liquidity of ASIT Biotech S.A.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ASIT Biotech S.A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.30 means the company has €0.30 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of ASIT Biotech S.A:

  • The MRQ is 0.298. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.298. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.298TTM0.2980.000
TTM0.298YOY0.389-0.090
TTM0.2985Y2.094-1.796
5Y2.09410Y2.618-0.524
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2985.117-4.819
TTM0.2985.755-5.457
YOY0.3895.854-5.465
5Y2.0946.511-4.417
10Y2.6186.222-3.604
1.3.2. Quick Ratio

Measures if ASIT Biotech S.A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ASIT Biotech S.A to the Biotechnology industry mean.
  • A Quick Ratio of 0.02 means the company can pay off €0.02 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ASIT Biotech S.A:

  • The MRQ is 0.022. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.022. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.022TTM0.0220.000
TTM0.022YOY0.383-0.361
TTM0.0225Y0.510-0.488
5Y0.51010Y0.352+0.159
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0224.284-4.262
TTM0.0224.664-4.642
YOY0.3834.787-4.404
5Y0.5105.218-4.708
10Y0.3525.182-4.830

1.4. Solvency of ASIT Biotech S.A.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ASIT Biotech S.A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ASIT Biotech S.A to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.10 means that ASIT Biotech S.A assets are financed with 209.7% credit (debt) and the remaining percentage (100% - 209.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ASIT Biotech S.A:

  • The MRQ is 2.097. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.097. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.097TTM2.0970.000
TTM2.097YOY1.614+0.483
TTM2.0975Y1.005+1.091
5Y1.00510Y0.913+0.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0970.278+1.819
TTM2.0970.277+1.820
YOY1.6140.306+1.308
5Y1.0050.367+0.638
10Y0.9130.403+0.510
1.4.2. Debt to Equity Ratio

Measures if ASIT Biotech S.A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ASIT Biotech S.A to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ASIT Biotech S.A:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.709-0.709
5Y0.70910Y4.415-3.706
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.315-0.315
TTM-0.317-0.317
YOY-0.319-0.319
5Y0.7090.403+0.306
10Y4.4150.462+3.953

2. Market Valuation of ASIT Biotech S.A

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings ASIT Biotech S.A generates.

  • Above 15 is considered overpriced but always compare ASIT Biotech S.A to the Biotechnology industry mean.
  • A PE ratio of -3.57 means the investor is paying €-3.57 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ASIT Biotech S.A:

  • The EOD is -3.681. Company is losing money. -2
  • The MRQ is -3.568. Company is losing money. -2
  • The TTM is -3.568. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-3.681MRQ-3.568-0.113
MRQ-3.568TTM-3.5680.000
TTM-3.568YOY-0.436-3.132
TTM-3.5685Y-4.878+1.310
5Y-4.87810Y-3.049-1.829
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.681-8.986+5.305
MRQ-3.568-9.792+6.224
TTM-3.568-16.243+12.675
YOY-0.436-20.876+20.440
5Y-4.878-16.665+11.787
10Y-3.049-14.732+11.683
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of ASIT Biotech S.A.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of ASIT Biotech S.A:

  • The MRQ is -1.865. Very Bad. -2
  • The TTM is -1.865. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-1.865TTM-1.8650.000
TTM-1.865YOY-0.481-1.384
TTM-1.8655Y-8.002+6.137
5Y-8.00210Y-8.0020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.865-0.032-1.833
TTM-1.8650.004-1.869
YOY-0.4810.016-0.497
5Y-8.0020.006-8.008
10Y-8.0020.003-8.005

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ASIT Biotech S.A is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.86 means the investor is paying €-0.86 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of ASIT Biotech S.A:

  • The EOD is -0.890. Bad. Book ratio is negative. -2
  • The MRQ is -0.862. Bad. Book ratio is negative. -2
  • The TTM is -0.862. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-0.890MRQ-0.862-0.027
MRQ-0.862TTM-0.8620.000
TTM-0.862YOY-1.635+0.773
TTM-0.8625Y15.975-16.837
5Y15.97510Y9.984+5.991
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.8901.835-2.725
MRQ-0.8622.006-2.868
TTM-0.8622.774-3.636
YOY-1.6353.453-5.088
5Y15.9752.713+13.262
10Y9.9842.402+7.582
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ASIT Biotech S.A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.067-0.0670%-0.486+630%-0.044-34%-0.032-52%
Book Value Growth--0.6510.6510%-0.646+199%4.559-86%28.519-98%
Book Value Per Share---0.257-0.2570%-0.191-26%0.100-356%0.101-356%
Book Value Per Share Growth--0.6510.6510%-0.646+199%4.559-86%28.519-98%
Current Ratio--0.2980.2980%0.389-23%2.094-86%2.618-89%
Debt To Asset Ratio--2.0972.0970%1.614+30%1.005+109%0.913+130%
Debt To Equity Ratio----0%-0%0.709-100%4.415-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.062-0.0620%-0.715+1049%-0.509+717%-0.400+544%
Eps Growth--1.9131.9130%0.907+111%1.011+89%1.011+89%
Free Cash Flow Per Share---0.063-0.0630%-0.597+849%-0.502+698%-0.393+525%
Free Cash Flow Per Share Growth--1.8951.8950%1.024+85%1.053+80%0.753+152%
Free Cash Flow To Equity Per Share---0.066-0.0660%-0.220+235%-0.022-67%-0.002-97%
Free Cash Flow To Equity Per Share Growth--1.7021.7020%-0.760+145%1.303+31%1.949-13%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.077--------
Intrinsic Value_10Y_min---0.909--------
Intrinsic Value_1Y_max---0.073--------
Intrinsic Value_1Y_min---0.071--------
Intrinsic Value_3Y_max---0.245--------
Intrinsic Value_3Y_min---0.231--------
Intrinsic Value_5Y_max---0.451--------
Intrinsic Value_5Y_min---0.411--------
Net Profit Margin----0%-0%-0%-393.2290%
Operating Margin----0%-0%-0%-387.7360%
Operating Ratio----0%-0%-0%388.151-100%
Pb Ratio-0.890-3%-0.862-0.8620%-1.635+90%15.975-105%9.984-109%
Pe Ratio-3.681-3%-3.568-3.5680%-0.436-88%-4.878+37%-3.049-15%
Peg Ratio---1.865-1.8650%-0.481-74%-8.002+329%-8.002+329%
Price Per Share0.229+3%0.2220.2220%0.312-29%2.428-91%1.518-85%
Price To Total Gains Ratio-3.439-3%-3.333-3.3330%-0.642-81%1.212-375%1.212-375%
Profit Growth--1.9131.9130%0.907+111%1.011+89%0.772+148%
Quick Ratio--0.0220.0220%0.383-94%0.510-96%0.352-94%
Return On Assets---0.265-0.2650%-2.300+768%-1.479+458%-1.375+419%
Return On Equity----0%-0%-2.6300%-8.6200%
Total Gains Per Share---0.067-0.0670%-0.486+630%-0.044-34%-0.032-52%
Total Gains Per Share Growth--1.8631.8630%-2.020+208%1.024+82%25.707-93%
Usd Book Value---6124681.500-6124681.5000%-4539981.300-26%2388354.060-356%2391587.588-356%
Usd Book Value Change Per Share---0.072-0.0720%-0.528+630%-0.047-34%-0.035-52%
Usd Book Value Per Share---0.280-0.2800%-0.207-26%0.109-356%0.109-356%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.068-0.0680%-0.777+1049%-0.553+717%-0.435+544%
Usd Free Cash Flow---1496661.300-1496661.3000%-14206869.900+849%-8876277.540+493%-5547673.463+271%
Usd Free Cash Flow Per Share---0.068-0.0680%-0.649+849%-0.545+698%-0.428+525%
Usd Free Cash Flow To Equity Per Share---0.071-0.0710%-0.239+235%-0.024-67%-0.002-97%
Usd Price Per Share0.249+3%0.2410.2410%0.339-29%2.639-91%1.650-85%
Usd Profit---1480357.800-1480357.8000%-17016506.400+1049%-12100240.320+717%-9527629.538+544%
Usd Revenue----0%-0%-0%2173.800-100%
Usd Total Gains Per Share---0.072-0.0720%-0.528+630%-0.047-34%-0.035-52%
 EOD+3 -2MRQTTM+0 -0YOY+23 -95Y+15 -1810Y+15 -20

3.2. Fundamental Score

Let's check the fundamental score of ASIT Biotech S.A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.681
Price to Book Ratio (EOD)Between0-1-0.890
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.022
Current Ratio (MRQ)Greater than10.298
Debt to Asset Ratio (MRQ)Less than12.097
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.265
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of ASIT Biotech S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.399
Ma 20Greater thanMa 500.239
Ma 50Greater thanMa 1000.232
Ma 100Greater thanMa 2000.262
OpenGreater thanClose0.235
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2020-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets5,138
Total Liabilities10,773
Total Stockholder Equity-5,635
 As reported
Total Liabilities 10,773
Total Stockholder Equity+ -5,635
Total Assets = 5,138

Assets

Total Assets5,138
Total Current Assets3,092
Long-term Assets3,092
Total Current Assets
Cash And Cash Equivalents 2,851
Net Receivables 233
Other Current Assets 1
Total Current Assets  (as reported)3,092
Total Current Assets  (calculated)3,085
+/- 7
Long-term Assets
Property Plant Equipment 129
Other Assets 1,917
Long-term Assets  (as reported)2,046
Long-term Assets  (calculated)2,046
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,367
Long-term Liabilities406
Total Stockholder Equity-5,635
Total Current Liabilities
Short Long Term Debt 5,292
Accounts payable 4,252
Other Current Liabilities 790
Total Current Liabilities  (as reported)10,367
Total Current Liabilities  (calculated)10,334
+/- 33
Long-term Liabilities
Other Liabilities 133
Long-term Liabilities Other 274
Long-term Liabilities  (as reported)406
Long-term Liabilities  (calculated)407
+/- 1
Total Stockholder Equity
Common Stock17,076
Other Stockholders Equity -1,292
Total Stockholder Equity (as reported)-5,635
Total Stockholder Equity (calculated)15,784
+/- 21,419
Other
Common Stock Shares Outstanding 21,893
Net Debt 2,441
Net Invested Capital -343
Net Tangible Assets -5,635
Net Working Capital -7,275



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
1,369
8,780
5,474
15,555
4,285
11,554
6,806
5,138
5,1386,80611,5544,28515,5555,4748,7801,369
   > Total Current Assets 
1,326
8,565
4,968
13,785
2,448
9,156
4,096
3,092
3,0924,0969,1562,44813,7854,9688,5651,326
       Cash And Cash Equivalents 
1,245
8,441
4,621
13,387
2,126
8,458
3,649
2,851
2,8513,6498,4582,12613,3874,6218,4411,245
       Net Receivables 
61
102
279
326
244
280
394
233
23339428024432627910261
       Inventory 
13
14
11
0
0
0
0
0
00000111413
       Other Current Assets 
7
8
57
72
78
1
0
1
10178725787
   > Long-term Assets 
0
0
0
1,770
1,837
2,397
2,710
2,046
2,0462,7102,3971,8371,770000
       Property Plant Equipment 
39
202
494
736
691
810
680
129
12968081069173649420239
       Long-term Assets Other 
0
0
0
1
1
-1
2,710
1
12,710-111000
> Total Liabilities 
1,327
1,348
6,332
2,423
3,086
5,086
10,983
10,773
10,77310,9835,0863,0862,4236,3321,3481,327
   > Total Current Liabilities 
443
1,279
6,332
2,004
2,654
4,621
10,543
10,367
10,36710,5434,6212,6542,0046,3321,279443
       Short-term Debt 
885
0
4,232
12
34
1,641
4,816
0
04,8161,64134124,2320885
       Short Long Term Debt 
885
0
4,232
12
34
1,641
4,856
5,292
5,2924,8561,64134124,2320885
       Accounts payable 
351
858
1,611
1,707
1,264
1,669
4,829
4,252
4,2524,8291,6691,2641,7071,611858351
       Other Current Liabilities 
92
421
318
42
1,225
1,192
730
790
7907301,1921,2254231842192
   > Long-term Liabilities 
0
0
0
419
432
465
440
406
406440465432419000
       Long term Debt Total 
0
0
0
0
0
465
307
0
030746500000
       Capital Lease Obligations 
0
0
0
0
0
0
73
0
073000000
       Long-term Liabilities Other 
0
0
0
0
4,285
465
1
274
27414654,2850000
> Total Stockholder Equity
42
7,432
-858
13,132
1,199
6,468
-4,177
-5,635
-5,635-4,1776,4681,19913,132-8587,43242
   Common Stock
14,293
11,625
11,625
17,506
9,989
14,350
17,076
17,076
17,07617,07614,3509,98917,50611,62511,62514,293
   Retained Earnings -60,049-58,887-43,233-28,915-24,445-12,481-4,766-20,038
   Capital Surplus 
0
0
0
0
0
37,034
38,630
0
038,63037,03400000
   Treasury Stock00000000
   Other Stockholders Equity 
374
573
-2
-1,886
-1,832
-1,683
-995
-1,292
-1,292-995-1,683-1,832-1,886-2573374



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2020-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-676
Operating Income-676-676
 
Operating Expense (+$)
Research Development53
Selling General Administrative478
Selling And Marketing Expenses-
Operating Expense676531
 
Net Interest Income (+$)
Interest Income74
Interest Expense-0
Net Interest Income-43874
 
Pretax Income (+$)
Operating Income-676
Net Interest Income-438
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,362-676
EBIT - interestExpense = -632
-1,362
-1,362
Interest Expense0
Earnings Before Interest and Taxes (ebit)-632-1,362
Earnings Before Interest and Taxes (ebitda)-683
 
After tax Income (+$)
Income Before Tax-1,362
Tax Provision-0
Net Income From Continuing Ops-1,362-1,362
Net Income-1,362
Net Income Applicable To Common Shares-1,362
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses1
Total Other Income/Expenses Net-438
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
CUBE1.CC
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CUBE1.CC.

CUBE1.CC Daily Candlestick Chart
CTSI.CC
31 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CTSI.CC.

CTSI.CC Daily Candlestick Chart
CTI.CC
31 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CTI.CC.

CTI.CC Daily Candlestick Chart
CRV1.CC
33 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CRV1.CC.

CRV1.CC Daily Candlestick Chart
CRU.CC
33 minutes ago

I found you a Golden Cross on the daily chart of CRU.CC.

CRU.CC Daily Candlestick Chart
CRPT.CC
33 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CRPT.CC.

CRPT.CC Daily Candlestick Chart
CREP.CC
33 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CREP.CC.

CREP.CC Daily Candlestick Chart
CORN.CC
35 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CORN.CC.

CORN.CC Daily Candlestick Chart
CORAL.CC
35 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of CORAL.CC.

CORAL.CC Daily Candlestick Chart
CONTENTBOX.CC
35 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CONTENTBOX.CC.

CONTENTBOX.CC Daily Candlestick Chart
CLV.CC
37 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CLV.CC.

CLV.CC Daily Candlestick Chart
CIV.CC
38 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of CIV.CC.

CIV.CC Daily Candlestick Chart
NGU24-NYM.COMM
7 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
7 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
7 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
7 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
7 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart